Testing the efficacy of antiangiogenic agents in advanced neuroendocrine tumors

被引：0
|
作者：
Beltran-Fabregat, Miquel [1 ]
Velasco-Capellas, Montserrat [1 ]
Menendez, Javier A. [1 ]
机构：
[1] Dr Josep Trueta Univ Hosp Girona, Catalan Inst Oncol ICO Girona, Hlth Serv Div Catalonia, Girona, Catalonia, Spain
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
10.1200/JCO.2007.11.3696
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：2624 / 2624
页数：1
相关论文
共 50 条
  • [31] Efficacy of Addition of Antiangiogenic Agents to Taxanes-Containing Chemotherapy in Advanced Nonsmall-Cell Lung Cancer
    Sheng, Jin
    Yang, Yun-Peng
    Yang, Bi-Jun
    Zhao, Yuan-Yuan
    Ma, Yu-Xiang
    Hong, Shao-Dong
    Zhang, Ya-Xiong
    Zhao, Hong-Yun
    Huang, Yan
    Zhang, Li
    MEDICINE, 2015, 94 (31)
  • [32] Antiangiogenic agents as a maintenance strategy for advanced epithelial ovarian cancer
    Monk, Bradley J.
    Dalton, Heather
    Farley, John H.
    Chase, Dana M.
    Benjamin, Ivor
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2013, 86 (02) : 161 - 175
  • [33] The efficacy and safety of sunitinib in patients with advanced well-differentiated pancreatic neuroendocrine tumors.
    Raymond, Eric
    Kulke, Matthew H.
    Qin, Shukui
    Schenker, Michael
    Cubillo, Antonio
    Lou, Wenhui
    Tomasek, Jiri
    Thiis-Evensen, Espen
    Xu, Jianming
    Racz, Karoly
    Croitoru, Adina E.
    Khasraw, Mustafa
    Sedlackova, Eva
    Borbath, Ivan
    Ruff, Paul
    Oberstein, Paul Eliezer
    Ito, Tetsuhide
    Fernandez, Kathrine C.
    Rosbrook, Brad
    Fazio, Nicola
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04)
  • [34] Efficacy and safety of everolimus in advanced low-to intermediate-grade neuroendocrine tumors.
    Gkiozos, Ioannis
    Syrigos, Konstantinos N.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [35] Impact of systemic and tumor lipid metabolism on everolimus efficacy in advanced pancreatic neuroendocrine tumors (pNETs)
    Vernieri, Claudio
    Pusceddu, Sara
    Fuca, Giovanni
    Indelicato, Pietro
    Centonze, Giovanni
    Castagnoli, Lorenzo
    Ferrari, Elisa
    Ajazi, Arta
    Pupa, Serenella
    Casola, Stefano
    Foiani, Marco
    Mazzaferro, Vincenzo
    Pruneri, Giancarlo
    Milione, Massimo
    de Braud, Filippo
    INTERNATIONAL JOURNAL OF CANCER, 2019, 144 (07) : 1704 - 1712
  • [36] Activity of Sunitinib in Patients With Advanced Neuroendocrine Tumors
    Bajetta, Emilio
    Guadalupi, Valentina
    Procopio, Giuseppe
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (02) : 319 - 320
  • [37] Management of Advanced Neuroendocrine Tumors With Hepatic Metastasis
    Khasraw, Mustafa
    Gill, Anthony
    Harrington, Tim
    Pavlakis, Nick
    Modlin, Irvin
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2009, 43 (09) : 838 - 847
  • [38] Emerging Therapies for Advanced Gastroenteropancreatic Neuroendocrine Tumors
    Gupta, Sameer
    Engstrom, Paul F.
    Cohen, Steven J.
    CLINICAL COLORECTAL CANCER, 2011, 10 (04) : 298 - 309
  • [39] Systemic Therapy for Advanced Pancreatic Neuroendocrine Tumors
    Kulke, Matthew H.
    SEMINARS IN ONCOLOGY, 2013, 40 (01) : 75 - 83
  • [40] Medical Treatment of Advanced Thoracic Neuroendocrine Tumors
    Ferolla, Piero
    THORACIC SURGERY CLINICS, 2014, 24 (03) : 351 - +
12345